Medicinal Genomics
PrivateLast Round
Series A
Apr 6, 2021
Total Funding Raised
$13.31M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Medicinal Genomics is a biotechnology company that provides genomic services, including microbial and plant pathogen testing, for the cannabis, hemp, and natural products industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Compliance
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medicinal Genomics Comparables
Compare Medicinal Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phylos Bioscience | 87% | |
| Segra International | 77% | |
| SC Labs | 73% |
Medicinal Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 6, 2021 | ||||
| Grant | Jan 26, 2017 | ||||
| Growth Equity | Jul 14, 2015 | ||||
| Early Funding | Oct 18, 2011 |
Medicinal Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| First Analysis | Series A |
| Bunker Hill Capital | Growth Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 50% MoM.
- Apr 6, 2021
$5M round led by First Analysis
Medicinal Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Medicinal Genomics's valuation, stock price, and market status.
Is Medicinal Genomics a public or private company?
Medicinal Genomics is a private company.
What is the current stock price of Medicinal Genomics?
Medicinal Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is Medicinal Genomics worth (valuation)?
Valuation information for Medicinal Genomics is not publicly available.
Can I buy Medicinal Genomics stock?
Medicinal Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Medicinal Genomics's last funding round?
Medicinal Genomics's most recent funding round was Series A on April 6, 2021.
Who are the main investors in Medicinal Genomics?
Key investors in Medicinal Genomics include Bunker Hill Capital.
Will Medicinal Genomics IPO soon?
No public IPO plans have been announced for Medicinal Genomics.
How can I track Medicinal Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medicinal Genomics's secondary market activity and sign up for updates.